Unity Biotechnology UBX Stock
Unity Biotechnology Price Chart
Unity Biotechnology UBX Financial and Trading Overview
| Unity Biotechnology stock price | 1.01 USD |
| Previous Close | 3.31 USD |
| Open | 3.36 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1100 |
| Day's Range | 3.07 - 3.36 USD |
| 52 Week Range | 1.46 - 18.5 USD |
| Volume | 195.62K USD |
| Avg. Volume | 437.63K USD |
| Market Cap | 45.68M USD |
| Beta (5Y Monthly) | 0.686971 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.63 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.83 USD |
UBX Valuation Measures
| Enterprise Value | 14.17M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.89577466 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 193.56229 |
| Price/Book (mrq) | 0.77883905 |
| Enterprise Value/Revenue | 60.056 |
| Enterprise Value/EBITDA | -0.307 |
Trading Information
Unity Biotechnology Stock Price History
| Beta (5Y Monthly) | 0.686971 |
| 52-Week Change | -46.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.5 USD |
| 52 Week Low | 1.46 USD |
| 50-Day Moving Average | 2.61 USD |
| 200-Day Moving Average | 3.35 USD |
UBX Share Statistics
| Avg. Volume (3 month) | 437.63K USD |
| Avg. Daily Volume (10-Days) | 241.63K USD |
| Shares Outstanding | 14.37M |
| Float | 13.13M |
| Short Ratio | 4.12 |
| % Held by Insiders | 1.78% |
| % Held by Institutions | 41.61% |
| Shares Short | 851.88K |
| Short % of Float | 6.01% |
| Short % of Shares Outstanding | 5.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -20363.55% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.49% |
| Return on Equity (ttm) | -94.90% |
Income Statement
| Revenue (ttm) | 236K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -35223000 USD |
| EBITDA | -46176000 USD |
| Net Income Avi to Common (ttm) | -51877000 USD |
| Diluted EPS (ttm) | -4.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 83.39M USD |
| Total Cash Per Share (mrq) | 5.81 USD |
| Total Debt (mrq) | 50.02M USD |
| Total Debt/Equity (mrq) | 85.31 USD |
| Current Ratio (mrq) | 3.952 |
| Book Value Per Share (mrq) | 4.083 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -47373000 USD |
| Levered Free Cash Flow (ttm) | -24497250 USD |
Profile of Unity Biotechnology
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 285 East Grand Avenue |
| ZIP | 94080 |
| Phone | 650-416-1192 |
| Website | https://unitybiotechnology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 31 |
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Q&A For Unity Biotechnology Stock
What is a current UBX stock price?
Unity Biotechnology UBX stock price today per share is 1.01 USD.
How to purchase Unity Biotechnology stock?
You can buy UBX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Unity Biotechnology?
The stock symbol or ticker of Unity Biotechnology is UBX.
Which industry does the Unity Biotechnology company belong to?
The Unity Biotechnology industry is Biotechnology.
How many shares does Unity Biotechnology have in circulation?
The max supply of Unity Biotechnology shares is 17.21M.
What is Unity Biotechnology Price to Earnings Ratio (PE Ratio)?
Unity Biotechnology PE Ratio is now.
What was Unity Biotechnology earnings per share over the trailing 12 months (TTM)?
Unity Biotechnology EPS is -1.63 USD over the trailing 12 months.
Which sector does the Unity Biotechnology company belong to?
The Unity Biotechnology sector is Healthcare.
Unity Biotechnology UBX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17353.18 USD — |
-0.07
|
4.18B USD — | 17256.2 USD — | 17362.6 USD — | — - | 4.18B USD — |
| NASDAQ Global Select Market Com NQGS | 8484.64 USD — |
-0.12
|
— — | 8441.28 USD — | 8494.07 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 924.54 USD — |
-0.7
|
— — | 922.17 USD — | 926.68 USD — | — - | — — |
- {{ link.label }} {{link}}